Patents Represented by Attorney Steve Zelzon

Find this attorney in the Justia Lawyer Directory

  • NK1 antagonists
    Patent number: 7241798
    Abstract: The invention is to compounds exhibiting neurokinin inhibitory properties, pharmaceutical compositions comprising same and methods of treatment for neurokinin-mediated conditions.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: July 10, 2007
    Assignee: Pfizer Inc.
    Inventors: Barbara E. Segelstein, Travis T. Wager, Willard M. Welch